Literature DB >> 27412790

Detection of human norovirus in intestinal biopsies from immunocompromised transplant patients.

Umesh C Karandikar1, Sue E Crawford1, Nadim J Ajami1, Kosuke Murakami1, Baijun Kou1, Khalil Ettayebi1, Genovefa A Papanicolaou2, Ubonvan Jongwutiwes2, Miguel-Angel Perales3,4, Jinru Shia5, David Mercer6, Milton J Finegold7,8, Jan Vinjé9, Robert L Atmar1,10, Mary K Estes1,10.   

Abstract

Human noroviruses (HuNoVs) can often cause chronic infections in solid organ and haematopoietic stem cell transplant (HSCT) patients. Based on histopathological changes observed during HuNoV infections, the intestine is the presumed site of virus replication in patients; however, the cell types infected by HuNoVs remain unknown. The objective of this study was to characterize histopathological changes during HuNoV infection and to determine the cell types that may be permissive for HuNoV replication in transplant patients. We analysed biopsies from HuNoV-infected and non-infected (control) transplant patients to assess histopathological changes in conjunction with detection of HuNoV antigens to identify the infected cell types. HuNoV infection in immunocompromised patients was associated with histopathological changes such as disorganization and flattening of the intestinal epithelium. The HuNoV major capsid protein, VP1, was detected in all segments of the small intestine, in areas of biopsies that showed histopathological changes. Specifically, VP1 was detected in enterocytes, macrophages, T cells and dendritic cells. HuNoV replication was investigated by detecting the non-structural proteins, RdRp and VPg. We detected RdRp and VPg along with VP1 in duodenal and jejunal enterocytes. These results provide critical insights into histological changes due to HuNoV infection in immunocompromised patients and propose human enterocytes as a physiologically relevant cell type for HuNoV cultivation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27412790      PMCID: PMC5756488          DOI: 10.1099/jgv.0.000545

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  38 in total

1.  Noroviruses: the perfect human pathogens?

Authors:  Aron J Hall
Journal:  J Infect Dis       Date:  2012-05-08       Impact factor: 5.226

2.  Norovirus and severe chronic gastroenteritis in pediatric stem cell transplantation: the plot thickens.

Authors:  Naim Alkhouri; Lara Danziger-Isakov
Journal:  Pediatr Transplant       Date:  2011-07-08

3.  Functional and topographical analyses of epitopes on the hemagglutinin (VP4) of the simian rotavirus SA11.

Authors:  J W Burns; H B Greenberg; R D Shaw; M K Estes
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

4.  Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation.

Authors:  Stefan Schwartz; Maria Vergoulidou; Eckart Schreier; Christoph Loddenkemper; Mark Reinwald; Martin Schmidt-Hieber; Willy A Flegel; Eckhard Thiel; Thomas Schneider
Journal:  Blood       Date:  2011-04-12       Impact factor: 22.113

5.  The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency.

Authors:  Jeremy M Woodward; Effrossyni Gkrania-Klotsas; Anthony Yk Cordero-Ng; Aloysious Aravinthan; Betty N Bandoh; Hongxiang Liu; Susan Davies; Hongyi Zhang; Philip Stevenson; Martin D Curran; Dinakantha Kumararatne
Journal:  Am J Gastroenterol       Date:  2015-01-27       Impact factor: 10.864

Review 6.  Norovirus infection in immunocompromised hosts.

Authors:  K Y Green
Journal:  Clin Microbiol Infect       Date:  2014-08       Impact factor: 8.067

7.  Enteric bacteria promote human and mouse norovirus infection of B cells.

Authors:  Melissa K Jones; Makiko Watanabe; Shu Zhu; Christina L Graves; Lisa R Keyes; Katrina R Grau; Mariam B Gonzalez-Hernandez; Nicole M Iovine; Christiane E Wobus; Jan Vinjé; Scott A Tibbetts; Shannon M Wallet; Stephanie M Karst
Journal:  Science       Date:  2014-11-07       Impact factor: 47.728

8.  Natural history of human calicivirus infection: a prospective cohort study.

Authors:  Barry Rockx; Matty De Wit; Harry Vennema; Jan Vinjé; Erwin De Bruin; Yvonne Van Duynhoven; Marion Koopmans
Journal:  Clin Infect Dis       Date:  2002-07-10       Impact factor: 9.079

9.  Plasmid-based human norovirus reverse genetics system produces reporter-tagged progeny virus containing infectious genomic RNA.

Authors:  Kazuhiko Katayama; Kosuke Murakami; Tyler M Sharp; Susana Guix; Tomoichiro Oka; Reiko Takai-Todaka; Akira Nakanishi; Sue E Crawford; Robert L Atmar; Mary K Estes
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-05       Impact factor: 11.205

10.  Noroviruses: The Most Common Pediatric Viral Enteric Pathogen at a Large University Hospital After Introduction of Rotavirus Vaccination.

Authors:  Hoonmo L Koo; Frederick H Neill; Mary K Estes; Flor M Munoz; Arlin Cameron; Herbert L DuPont; Robert L Atmar
Journal:  J Pediatric Infect Dis Soc       Date:  2012-08-03       Impact factor: 3.164

View more
  48 in total

1.  A Secreted Viral Nonstructural Protein Determines Intestinal Norovirus Pathogenesis.

Authors:  Sanghyun Lee; Hejun Liu; Craig B Wilen; Zoi E Sychev; Chandni Desai; Barry L Hykes; Robert C Orchard; Broc T McCune; Ki-Wook Kim; Timothy J Nice; Scott A Handley; Megan T Baldridge; Gaya K Amarasinghe; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2019-05-23       Impact factor: 21.023

Review 2.  The Dual Tropism of Noroviruses.

Authors:  Christiane E Wobus
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

3.  Norovirus in health care and implications for the immunocompromised host.

Authors:  Pearlie P Chong; Robert L Atmar
Journal:  Curr Opin Infect Dis       Date:  2019-08       Impact factor: 4.915

4.  Targeting macrophage- and intestinal epithelial cell-specific microRNAs against norovirus restricts replication in vivo.

Authors:  Lucy Thorne; Jia Lu; Yasmin Chaudhry; Dalan Bailey; Ian Goodfellow
Journal:  J Gen Virol       Date:  2018-04-23       Impact factor: 3.891

Review 5.  Norovirus Regulation by Host and Microbe.

Authors:  Megan T Baldridge; Holly Turula; Christiane E Wobus
Journal:  Trends Mol Med       Date:  2016-11-22       Impact factor: 11.951

6.  Human norovirus exhibits strain-specific sensitivity to host interferon pathways in human intestinal enteroids.

Authors:  Shih-Ching Lin; Lin Qu; Khalil Ettayebi; Sue E Crawford; Sarah E Blutt; Matthew J Robertson; Xi-Lei Zeng; Victoria R Tenge; B Vijayalakshmi Ayyar; Umesh C Karandikar; Xiaomin Yu; Cristian Coarfa; Robert L Atmar; Sasirekha Ramani; Mary K Estes
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-09       Impact factor: 11.205

7.  Replication of human noroviruses in stem cell-derived human enteroids.

Authors:  Khalil Ettayebi; Sue E Crawford; Kosuke Murakami; James R Broughman; Umesh Karandikar; Victoria R Tenge; Frederick H Neill; Sarah E Blutt; Xi-Lei Zeng; Lin Qu; Baijun Kou; Antone R Opekun; Douglas Burrin; David Y Graham; Sasirekha Ramani; Robert L Atmar; Mary K Estes
Journal:  Science       Date:  2016-08-25       Impact factor: 47.728

8.  Replication of Human Norovirus RNA in Mammalian Cells Reveals Lack of Interferon Response.

Authors:  Lin Qu; Kosuke Murakami; James R Broughman; Margarita K Lay; Susana Guix; Victoria R Tenge; Robert L Atmar; Mary K Estes
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

9.  IL-22-induced cell extrusion and IL-18-induced cell death prevent and cure rotavirus infection.

Authors:  Zhan Zhang; Jun Zou; Zhenda Shi; Benyue Zhang; Lucie Etienne-Mesmin; Yanling Wang; Xuyan Shi; Feng Shao; Benoit Chassaing; Andrew T Gewirtz
Journal:  Sci Immunol       Date:  2020-10-02

10.  CD300lf Conditional Knockout Mouse Reveals Strain-Specific Cellular Tropism of Murine Norovirus.

Authors:  Vincent R Graziano; Mia Madel Alfajaro; Cameron O Schmitz; Renata B Filler; Madison S Strine; Jin Wei; Leon L Hsieh; Megan T Baldridge; Timothy J Nice; Sanghyun Lee; Robert C Orchard; Craig B Wilen
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.